BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 720482)

  • 1. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species variation in dopamine receptor binding.
    Creese I; Stewart K; Snyder SH
    Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of antiparkinsonian ergot derivatives to the dopamine receptor.
    Weir RL; Hruska RE; Silbergeld EK
    Psychopharmacology (Berl); 1981; 75(2):119-23. PubMed ID: 6798600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine.
    Titeler M; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):291-2. PubMed ID: 477726
    [No Abstract]   [Full Text] [Related]  

  • 12. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
    Titeler M; Seeman P
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-Spiroperidol labels dopamine receptors in pituitary and brain.
    Creese I; Schneider R; Snyder SH
    Eur J Pharmacol; 1977 Dec; 46(4):377-81. PubMed ID: 590345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
    Creese I; Padgett L; Fazzini E; Lopez F
    Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
    [No Abstract]   [Full Text] [Related]  

  • 17. Hallucinogen binding to dopamine/neuroleptic receptors.
    Whitaker PM; Seeman P
    J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3H-spiperone binding in caudate nuclei of rabbits and rats.
    Hernandez LL; Powell DA
    Pharmacol Biochem Behav; 1987 Feb; 26(2):253-8. PubMed ID: 3575350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.